Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-09-010202
Filing Date
2009-11-16
Accepted
2009-11-16 14:48:04
Documents
5
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a2195509z10-q.htm 10-Q 274553
2 EXHIBIT 31.1 a2195509zex-31_1.htm EX-31.1 7962
3 EXHIBIT 31.2 a2195509zex-31_2.htm EX-31.2 7970
4 EXHIBIT 32.1 a2195509zex-32_1.htm EX-32.1 4542
5 EXHIBIT 32.2 a2195509zex-32_2.htm EX-32.2 4819
  Complete submission text file 0001047469-09-010202.txt   301488
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 203823853 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-131722 | Film No.: 091185995
SIC: 2834 Pharmaceutical Preparations